Drug information for ADDERALL XR 30
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE, EXTENDED RELEASE; ORAL
7.5MG;7.5MG;7.5MG;7.5MG
Prescription
(Reference Drug)
AMPHETAMINE ASPARTATE
;
AMPHETAMINE SULFATE
;
DEXTROAMPHETAMINE SACCHARATE
;
DEXTROAMPHETAMINE SULFATE
Amphetamine
SHIRE
21303
2012-02-10 Letter
2012-02-09 Medication Guide
2012-02-09 Label
2010-11-18 Letter
2010-11-18 Letter
2010-11-17 Medication Guide
2010-11-17 Label
2010-11-17 Label
2010-11-17 Medication Guide
2009-12-04 Medication Guide
2008-11-13 Letter
2007-06-22 Review
2007-05-29 Letter
2007-05-29 Label
2006-07-27 Label
2006-07-27 Letter
2006-06-20 Label
2006-06-20 Letter
2005-07-26 Label
2005-07-26 Letter
2005-04-15 Healthcare Professional Sheet
2005-04-15 Other Important Information from FDA
2005-02-07 Label
2004-08-12 Letter
2004-05-25 Review
2002-05-22 Label
2002-05-22 Letter
2001-10-11 Label
2001-10-11 Letter
Drug Adverse Effects information for ADDERALL XR 30
Role code
Indications
Reaction
# Reports
PS
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
DRUG INEFFECTIVE
1
PS
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
PRODUCT SUBSTITUTION ISSUE
1
Ads by Google